Clinical StudiesBeta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the antiarrhythmics versus implantable defibrillators (AVID) trial☆
Under an Elsevier user license
open archive
Abbreviations
ACE
angiotensin-converting enzyme
AVID
Antiarrhythmics Versus Implantable Defibrillators
CAMIAT
Canadian Amiodarone Myocardial Infarction Arrhythmia Trial
EMIAT
European Myocardial Infarct Amiodarone Trial
CI
confidence interval
ICD
implantable cardioverter defibrillator
LV
left ventricular
MI
myocardial infarction
NYHA
New York Heart Association
RR
relative risk
VF
ventricular fibrillation
VT
ventricular tachycardia
Cited by (0)
- ☆
This study was supported by a contract (N01 HC-25117) with the National Heart, Lung, and Blood Institute. Dr. Exner is a Clinician-Scientist (phase I) of the Medical Research Council of Canada and Research Fellow of the Alberta Heritage Foundation for Medical Research.
Copyright © 1999 American College of Cardiology. Published by Elsevier Inc. All rights reserved.